Status:

WITHDRAWN

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Lead Sponsor:

ANRS, Emerging Infectious Diseases

Collaborating Sponsors:

European and Developing Countries Clinical Trials Partnership (EDCTP)

Ludwig-Maximilians - University of Munich

Conditions:

HIV

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

In the well recognized context of HIV infection chronicity, it is now crucial to identify and evaluate effective, well tolerated and affordable second line regimen in resources limited countries where...

Eligibility Criteria

Inclusion

  • age 18 and above
  • out patient
  • documented HIV-1 infection
  • first line treatment failure:
  • after first-line antiretroviral treatment with a combination including a non-nucleoside reverse transcriptase inhibitor and two nucleoside reverse transcriptase inhibitors
  • two measurements of plasma HIV RNA levels \> 1000 copies/mL after at least 6 months of uninterrupted treatment or without any major modification
  • satisfactory compliance (\>80%) to 1st line antiretroviral treatment
  • signed informed consent
  • agreement for contraception for women of childbearing age

Exclusion

  • HIV-2 infection or HIV-1/HIV-2 coinfection
  • uncontrolled, ongoing opportunistic infection or of any severe or progressive disease including active TB
  • first line antiretroviral treatment with a protease inhibitor or tenofovir
  • ongoing treatment with rifampicin
  • severe hepatic insufficiency (PT \< 50%)
  • ALT \< 3 times the upper limit of normal
  • creatinine clearance calculated by Cockcroft's formula \< 50 mL/min
  • Hb \<=8 g/dL; platelets \< 50,000 cells/mm3; neutrophils \< 500 cells/mm3
  • pregnancy and lactation

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01255371

Start Date

March 1 2012

End Date

December 1 2014

Last Update

November 8 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Tshepang clinic, Limpopo University

Pretoria, South Africa

2

NIMR-Mbeya Medical Research Program-Mbeya Referral Hospital

Mbeya, Tanzania

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir | DecenTrialz